Reverse-phase HPLC: difference between revisions
Diff·revision 12 → 13·17:29, 7 Dec 2024
Difference between revision 12 and revision 13 of Reverse-phase HPLC. 6 lines changed; the page grew by 142 bytes.
| Revision 12 — 09:53, 19 Nov 2024 TechnicianTeal (talk) correct the resolution formula — the denominator is the sum of the widths 3,742 bytes +697 | Revision 13 — 17:29, 7 Dec 2024 CategoryBot (talk) bot: normalise unit spacing 3,884 bytes +142 | ||
|---|---|---|---|
| 41 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 41 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 42 | 42 | ||
| + | 43 | == See also == | |
| + | 44 | * [[High-performance liquid chromatography]] | |
| + | 45 | * [[Area percent purity]] | |
| + | 46 | * [[Retention time]] | |
| + | 47 | * [[Trifluoroacetate counterion]] | |
| + | 48 | ||
| 43 | {{DEFAULTSORT:Reverse-phase HPLC}} | 49 | {{DEFAULTSORT:Reverse-phase HPLC}} |
| 44 | [[Category:Chromatography]] | 50 | [[Category:Chromatography]] |